The 8 Weeks, Multicenter, Randomized, Double-blind, Clinical Study To Evaluate Efficacy Of Treatment With Losartan/Amlodipine 100/5 mg Combination Compared To Amlodipine 10 mg Monotherapy In Hypertensive Patients Who Are Not Appropriately Respond To Amlodipine 5 mg Monotherapy.
Phase of Trial: Phase IV
Latest Information Update: 08 May 2017
At a glance
- Drugs Amlodipine/losartan (Primary) ; Amlodipine
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Merck & Co
- 02 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Apr 2013 Planned End Date changed from 1 May 2013 to 1 Apr 2013 as reported by ClinicalTrials.gov.
- 06 Mar 2013 Planned end date changed from 1 Sep 2013 to 1 May 2013 as reported by ClinicalTrials.gov.